Christine S Walsh MD MS
Gynecologic Oncology
Associate Professor, Obstetrics & Gynecology, UCLA School of Medicine Director of Gynecologic Oncology Fellowship at UCLA/Cedars-Sinai Medical Center
Join to View Full Profile
1635 Aurora CtAurora, CO 80045
Phone+1 720-848-0000
Fax+1 310-967-1142
Dr. Walsh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalResidency, Obstetrics and Gynecology, 1998 - 2002
Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Certifications & Licensure
CO State Medical License 2020 - 2027
NE State Medical License 2021 - 2026
CA State Medical License 2002 - 2025
WY State Medical License 2021 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Evaluating a Shared Decision Making Program for Crohn's Disease Start of enrollment: 2014 Mar 01
- A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer Start of enrollment: 2016 Feb 08
Publications & Presentations
PubMed
- 10 citationsDNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers.Nicole Gull, Michelle R Jones, Pei-Chen Peng, Simon G Coetzee, Tiago C Silva
Journal of Experimental & Clinical Cancer Research. 2022-07-27 - 3 citationsThe Masquerading, Masculinizing Tumor: A Case Report and Review of the Literature.Alexis LeVee, Nissi Suppogu, Christine Walsh, Wendy Sacks, James A. Simon
Journal of Women's Health. 2021-07-12 - 15 citationsPhase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.Christine Walsh, Mitchell Kamrava, Andre Rogatko, Sungjin Kim, Andrew J. Li
Plos One. 2021-06-03
Journal Articles
- Variants in Genes Encoding Small GTPases and Association with Epithelial Ovarian Cancer SusceptibilityJulie M Cunningham, Robert P Edwards, Elizabeth M Poole, Tanja Pejovic, Karen Lu, Kunle Odunsi, Beth Y Karlan, Christine S Walsh, Douglas A Levine, Andrew Berchuck, Da..., PLoS One
Press Mentions
Statin Therapy to Reduce Progression in Women with Platinum Sensitive Ovarian CancerJuly 7th, 2020
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
